Pharmacovigilance & Safety
This track provides an overview of, and insight into, the global patient safety environment for medicinal products and medical devices. The focus is on pragmatic vision for ensuring patient safety and ensuring that the patient voice is properly heard in the complex and evolving safety ecosystem. The forward-thinking sessions will address the complexities of operating in a global environment and look at how we apply new technologies and methods for streamlining safety systems and processes. This will help enhance patient safety as products become progressively more complex, new data sources drive new analytical techniques and regulatory requirements.
Who is This Track Designed For?
Anyone curious/interested, established safety professionals who are seeking to increase their network of like-minded colleagues; share their thoughts and practices with others; learn the most current safety regulatory views and gain practical knowledge in key areas in pharmacovigilance.
Topic Leader
James Whitehead
Senior Director, Device & Digital Safety
AstraZeneca, United Kingdom
Willemijn van der Spuij
Executive Director, WorldWide Patient Safety International, Europe
Bristol Myers Squibb, Switzerland